잠시만 기다려 주세요. 로딩중입니다.

結核性 新患者의 化學療法에 있어서 1314TH를 最初부터 主藥으로 使用한 臨床硏究

The Primary Use of 1314TH in the Initial Treatment of Tuberculosis

최신의학 1963년 6권 9호 p.19 ~ 22
이재규,
소속 상세정보
이재규 (  ) - 이재규병원

Abstract


1. Clinical studies have already proved the remarkable effectiveness of the new drug, 1314 TH, in the treatment of the cases resistant to the major drugs, namely, PAS, INH and streptomycin.
In this study further clinical evidences in the chemotherapy of previously untreated tuberculosis patients indicated the use of 1314TH as the drug of primary choice.
2. Early cavities, regardless of the size, disappeared in four, or at the latest eight, weeks and reabsorption occurred also in four to eight weeks in pneumonitic, infiltrative and productive types, and thus, the over-all period of hospitalization in the long term patients has been remarkably shortened and their rehabi4tation has been dramatically facilitated by the primary use of 1314 TH.
3. 1314 TH also, showed an excellent result in the treatment of tuberculous meningitis patients.

키워드

원문 및 링크아웃 정보

등재저널 정보